Your Messages Inbox
Your Article Summary
See Latest ArticlesProtox Appoints Chief Financial Officer
Protox Therapeutics , 03/24/09
Protox Therapeutics Inc. , a leader in the development of receptor targeted fusion proteins, announced that John Parkinson has been appointed Chief Financial Officer of the Company, effective immediately. Mr. Parkinson will replace David Swetlow, Vice President of Finance and Operations, who is leaving Protox to pursue entrepreneurial opportunities.
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
ImmunoGen, Inc., 12/18/09
CCHIT Appoints Officers
HealthDataManagement, 12/18/09
Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
Boston Scientific, 12/17/09
Article Search
Sponsor